相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。New insights into the pathogenesis and treatment of chronic myeloproliferative disorders
Ruben A. Mesa
CURRENT OPINION IN HEMATOLOGY (2008)
New mutations of MPL in primitive myelofibrosis:: only the MPL W515 mutations promote a G1/S-phase transition
R. Chaligne et al.
LEUKEMIA (2008)
The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites
Y. Shiozawa et al.
LEUKEMIA (2008)
Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms:: a critical reappraisal
A. M. Vannucchi et al.
LEUKEMIA (2008)
Mesenchymal stem cells from JAK2(V617F) mutant patients with primary myelolibrosis do not harbor JAK2 mutant allele
Lisa Pieri et al.
LEUKEMIA RESEARCH (2008)
Hypermethylation of CXCR4 promoter in CD34+ cells from patients with primary myelofibrosis
Costanza Bogani et al.
STEM CELLS (2008)
Uncertainty in the niches that maintain haematopoietic stem cells
Mark J. Kiel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis - impact on disease phenotype
Thomas Stauffer Larsen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
The role of the donor in the repair of the marrow vascular niche following hematopoietic stem cell transplant
William B. Slayton et al.
STEM CELLS (2007)
Increased angiogenesis in chronic idiopathic myelofibrosis: vascular endothelial growth factor as a prominent angiogenic factor
Michael Steurer et al.
HUMAN PATHOLOGY (2007)
Effects of chromatin-modifying agents on CD34+ cells from patients with idiopathic myelofibrosis
Jun Shi et al.
CANCER RESEARCH (2007)
Bone changes in myelofibrosis with myeloid metaplasia:: a histomorphometric and microcomputed tomographic study
Aline Schmidt et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
The expression of CXCR4 is down-regulated on the CD34+cells of patients with myelofibrosis with myeloid metaplasia
Vittorio Rosti et al.
BLOOD CELLS MOLECULES AND DISEASES (2007)
Molecular profiling of CD34(+) cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1)
Paola Guglielmelli et al.
STEM CELLS (2007)
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia
Daniella M. B. Kerbauy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Perspectives of gamma delta T cells in tumor immunology
Dieter Kabelitz et al.
CANCER RESEARCH (2007)
Mechanisms of disease: The myeloproliferative disorders
Peter J. Campbell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Aberrant collagenase expression in chronic idiopathic myelofibrosis is related to the stage of disease but not to the JAK2 mutation status
Oliver Bock et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
MPLW515L is anovel somatic activating mutation in myelofibrosis with myeloid metaplasia
Yana Pikman et al.
PLOS MEDICINE (2006)
Activated Jak2 with the V617F point mutation promotes G1/S phase transition
Christoph Walz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Pathogenesis of myelofibrosis with myeloid metaplasia
A Tefferi
JOURNAL OF CLINICAL ONCOLOGY (2005)
Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia
M Massa et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Hematopoietic stem cells and their niche
T Suda et al.
TRENDS IN IMMUNOLOGY (2005)
Stem cell dysregulation in myelofibrosis with myeloid metaplasia:: Current data on growth factor and transcription factor involvement
MC Martyré et al.
SEMINARS IN ONCOLOGY (2005)
Osteosclerosis in advanced chronic idiopathic myelofibrosis is associated with endothelial overexpression of osteoprotegerin
O Bock et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
A role for niches in hematopoietic cell development
B Heissig et al.
HEMATOLOGY (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
EJ Baxter et al.
LANCET (2005)
Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia
G Barosi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis
ST Avecilla et al.
NATURE MEDICINE (2004)
Osteosclerosis in idiopathic myelofibrosis is related to the overproduction of osteoprotegerin (OPG)
JC Wang et al.
EXPERIMENTAL HEMATOLOGY (2004)
Impaired NK cell differentiation of blood-derived CD34+ progenitors from patients with myeloid metaplasia with myelofibrosis
D Briard et al.
CLINICAL IMMUNOLOGY (2003)
Fibroblasts from human spleen regulate NK cell differentiation from blood CD34+ progenitors via cell surface IL-15
D Briard et al.
JOURNAL OF IMMUNOLOGY (2002)
Patients with idiopathic myelofibrosis show increased CD34+ cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia
B Andréasson et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2002)
Effects of human fibroblasts from myelometaplasic and non-myelometaplasic hematopoietic tissues on CD34+ stem cells
D Brouty-Boyé et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
NF-κB as a central mediator in the induction of TGF-β in monocytes from patients with idiopathic myelofibrosis:: An inflammatory response beyond the realm of homeostasis
P Rameshwar et al.
JOURNAL OF IMMUNOLOGY (2000)
Assessment of peripheral blood lymphocyte subsets in idiopathic myelofibrosis
F Cervantes et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2000)
Medical progress: Myelofibrosis with myeloid metaplasia.
A Tefferi
NEW ENGLAND JOURNAL OF MEDICINE (2000)